Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

2.3K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.3K
iPS Cell Differentiation01:22

iPS Cell Differentiation

3.0K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.0K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

3.4K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.4K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.6K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.6K
Stem Cell Culture01:17

Stem Cell Culture

6.0K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
6.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Homozygous SGCB splice-site variant causes isolated dilated cardiomyopathy through sarcoglycan complex destabilization in East Asians.

The Journal of clinical investigation·2026
Same author

Translation of expanded CGG repeats in LRP12 associated oculopharyngodistal myopathy.

Acta neuropathologica communications·2026
Same author

Embryonic lineage-specific iPSC-derived mesenchymal stem/stromal cells exhibit different morphologies and intrinsic functions.

iScience·2026
Same author

Development of Electric Field Stimulation (EFS)-Mediated Skeletal Muscle Training with iPSCs.

Methods in molecular biology (Clifton, N.J.)·2025
Same author

Diversity challenges and reconciles genetics in facioscapulohumeral muscular dystrophy.

Journal of human genetics·2025
Same author

Aberrant lysosomal dynamics disrupt myogenesis via mTORC1 signalling in X-linked myotubular myopathy.

Brain : a journal of neurology·2025

Related Experiment Video

Updated: Jan 16, 2026

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders
10:28

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders

Published on: April 3, 2021

7.0K

[iPS cell-based therapy for muscular disorders].

Hidetoshi Sakurai1

  • 1Sakurai-Lab, Department of Clinical Application, Center for iPS Cell Research and Application (CiRA), Kyoto University.

Rinsho Shinkeigaku = Clinical Neurology
|September 28, 2025
PubMed
Summary

Induced pluripotent stem cells (iPSCs) offer new hope for intractable muscular diseases. Researchers successfully used iPSC-derived cells for transplantation therapies in mouse models, showing significant muscle regeneration and potential for long-term effects.

Keywords:
Cell therapyMesenchymal stromal cellMuscle stem cellMuscular dystrophyiPS cell

More Related Videos

Transplantation of Induced Pluripotent Stem Cell-derived Mesoangioblast-like Myogenic Progenitors in Mouse Models of Muscle Regeneration
10:03

Transplantation of Induced Pluripotent Stem Cell-derived Mesoangioblast-like Myogenic Progenitors in Mouse Models of Muscle Regeneration

Published on: January 20, 2014

10.1K
Molecular Imaging to Target Transplanted Muscle Progenitor Cells
09:24

Molecular Imaging to Target Transplanted Muscle Progenitor Cells

Published on: March 27, 2013

9.4K

Related Experiment Videos

Last Updated: Jan 16, 2026

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders
10:28

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders

Published on: April 3, 2021

7.0K
Transplantation of Induced Pluripotent Stem Cell-derived Mesoangioblast-like Myogenic Progenitors in Mouse Models of Muscle Regeneration
10:03

Transplantation of Induced Pluripotent Stem Cell-derived Mesoangioblast-like Myogenic Progenitors in Mouse Models of Muscle Regeneration

Published on: January 20, 2014

10.1K
Molecular Imaging to Target Transplanted Muscle Progenitor Cells
09:24

Molecular Imaging to Target Transplanted Muscle Progenitor Cells

Published on: March 27, 2013

9.4K

Area of Science:

  • Regenerative Medicine
  • Stem Cell Biology
  • Musculoskeletal Research

Background:

  • Intractable muscular diseases pose significant therapeutic challenges.
  • Induced pluripotent stem cells (iPSCs) possess unlimited proliferative and multipotent potential for disease modeling and therapy development.
  • Current research focuses on cell therapy and drug screening using iPSCs for muscular dystrophies.

Purpose of the Study:

  • To develop novel cell therapies for intractable muscular diseases using iPSC-derived cells.
  • To investigate the efficacy of iPSC-derived skeletal muscle stem cells in Duchenne muscular dystrophy (DMD) models.
  • To explore the therapeutic potential of iPSC-derived mesenchymal stromal cells (iMSCs) in Ullrich congenital muscular dystrophy (UCMD) models.

Main Methods:

  • Developed a differentiation induction method for skeletal muscle stem cells from iPSCs, mimicking developmental stages.
  • Performed cell transplantation of iPSC-derived skeletal muscle stem cells into DMD model mice.
  • Developed a differentiation method for mesenchymal stromal cells (MSCs) from iPSCs and transplanted iMSCs into UCMD model mice.

Main Results:

  • Cell transplantation into DMD model mice regenerated over 10% dystrophin-positive fibers and engrafted as satellite cells, suggesting long-term therapeutic effects.
  • Regeneration of dystrophin-positive myofibers primarily ameliorated muscle fatigue tolerance, not maximal contraction force, in DMD models.
  • Transplantation of iMSCs into UCMD model mice restored collagen type VI, enhancing muscle regeneration, an effect not observed with somatic MSCs.

Conclusions:

  • iPSC-derived skeletal muscle stem cells show promise for cell transplantation therapy in DMD, improving muscle function and offering sustained benefits.
  • iPSC-derived MSCs demonstrate therapeutic efficacy in UCMD models by restoring collagen type VI, highlighting a specific advantage over somatic MSCs.
  • Further research is ongoing to identify specific factors in iMSCs responsible for enhanced muscle regeneration.